CASI Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $96.2M
Liabilities Breakdown FY2022
Total Liabilities: $29.3M
Asset Breakdown
Total Assets: $96.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $47.1M | 49.0% |
| Accounts Receivable | $13.0M | 13.5% |
| Inventory | $6.1M | 6.4% |
| Property, Plant & Equipment | $11.8M | 12.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $1.1M | 1.1% |
| Other Assets | $17.1M | 17.8% |
Liabilities Breakdown
Total Liabilities: $29.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.3M | 11.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $26.0M | 88.8% |